Vogt Frederick G 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Jun 4, 2025
Insider Transaction Report
Form 4
Vogt Frederick G
DirectorInterim CEO & General Counsel
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-06-02−10,417→ 31,252 total→ Common stock (10,417 underlying) - Exercise/Conversion
Restricted Stock Units
2025-06-02−41,668→ 291,682 total→ Common stock (41,668 underlying) - Exercise/Conversion
Common Stock
2025-06-02+52,085→ 426,731 total - Tax Payment
Common Stock
2025-06-02$1.76/sh−22,127$38,944→ 404,604 total
Footnotes (7)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.
- [F7]Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.